George Sekulich
President bij EMMAUS LIFE SCIENCES, INC.
Vermogen: 40 $ op 31-03-2024
Profiel
George Sekulich is currently the Co-President, Director & Chief Commercial Officer at Emmaus Life Sciences, Inc. since 2023.
He is also currently the Chief Information Officer at EMI Holding, Inc. since 2014.
Previously, he worked as the Owner at Magellan Network Systems, Inc. Mr. Sekulich completed his undergraduate degree at California State University-Dominguez Hills.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-02-2024 | 385 ( 0.00% ) | 40 $ | 31-03-2024 |
Actieve functies van George Sekulich
| Bedrijven | Functie | Begin |
|---|---|---|
| EMMAUS LIFE SCIENCES, INC. | President | 23-08-2023 |
EMI Holding, Inc.
 EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Chief Tech/Sci/R&D Officer | 01-09-2014 |
Eerdere bekende functies van George Sekulich
| Bedrijven | Functie | Einde |
|---|---|---|
| Magellan Network Systems, Inc. | Corporate Officer/Principal | - |
Opleiding van George Sekulich
| California State University-Dominguez Hills | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EMMAUS LIFE SCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Health Technology |
| Magellan Network Systems, Inc. |
